MAINTENANCE THERAPY
Clinical trials for MAINTENANCE THERAPY explained in plain language.
Never miss a new study
Get alerted when new MAINTENANCE THERAPY trials appear
Sign up with your email to follow new studies for MAINTENANCE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to keep high-risk throat cancer at bay
Disease control Recruiting nowThis phase 3 trial tests whether adding toripalimab (an immunotherapy) to capecitabine (a chemotherapy pill) as maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. The study enrolls 264 adults aged 18-70 who have completed …
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New hope for AML patients: study tests better drug to keep leukemia away after transplant
Disease control Recruiting nowThis study tests whether a newer drug, gilteritinib, works better than the current standard, sorafenib, to prevent leukemia from coming back after a stem cell transplant. About 594 adults and teens with a specific genetic mutation (FLT3-ITD) will be randomly assigned to take one …
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
Custom-Made vaccine could keep leukemia in remission
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after standard chemotherapy. The vaccine aims to train the immune system to recognize an…
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New drug combo aims to keep leukemia in remission after transplant
Disease control Recruiting nowThis study tests whether menin inhibitors can help prevent leukemia from returning after a stem cell transplant. About 20 adults with certain genetic types of acute leukemia will take these drugs as part of their regular care. Researchers will track how many patients stay cancer-…
Matched conditions: MAINTENANCE THERAPY
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 05:45 UTC